Compare AU
Compare VDAL vs. IXJ
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are VDAL and IXJ. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.
Community Stats
VDAL | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 61 | 260 |
Median incremental investment | $1,006.75 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,089.88 | $1,862.42 |
Average age group | > 35 | 26 - 35 |
Key Summary
VDAL | IXJ | |
|---|---|---|
Strategy | VDAL.AX was created on 2025-03-04 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified All Growth Index ETF seeks to track the weighted average return of the various indices of the Underlying Funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax. | IXJ.AX was created on 2001-11-13 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or smallcapitalisation stocks |
Top 3 holdings | Vanguard Diversified All Growth Index ETF (100 %) | Eli Lilly and Company (8.25 %) UnitedHealth Group Incorporated (5.81 %) Johnson & Johnson (4.72 %) |
Top 3 industries | Other (99.98 %) Communication Services (0.02 %) | |
Top 3 countries | United States (99.97 %) | |
Management fee | 0.27 % | 0.46 % |
Key Summary
VDAL | IXJ | |
|---|---|---|
Issuer | Vanguard | iShares |
Tracking index | 40% S&P/ASX 300 Index - 29.5% MSCI World ex-Australia Index - 18% MSCI World ex-Australia Index - 7% MSCI World ex-Australia Small Cap Index - 5.5% MSCI Emerging Markets Index - Benchmark TR Net | S&P Global 1200 Healthcare Sector Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.27 % | 0.46 % |
Price | $49.69 | $132.88 |
Size | N/A | $1.340 billion |
10Y return | N/A | 91.35 % |
Annual dividend/ distribution yield (5Y) | 0.04 % | 1.26 % |
Market | ASX | ASX |
First listed date | 04/03/2025 | 11/03/2009 |
Purchase fee | $6.50 | $6.50 |
Community Stats
VDAL | IXJ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 61 | 260 |
Median incremental investment | $1,006.75 | $1,000.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,089.88 | $1,862.42 |
Average age group | > 35 | 26 - 35 |
Pros and Cons
VDAL | IXJ | |
|---|---|---|
Pros |
|
|
Cons |
|
|
VDAL | IXJ |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Lower distribution yield | Higher distribution yield |